<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36417267</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2673-3986</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Epidemiologia (Basel, Switzerland)</Title><ISOAbbreviation>Epidemiologia (Basel)</ISOAbbreviation></Journal><ArticleTitle>Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>49</StartPage><EndPage>67</EndPage><MedlinePgn>49-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/epidemiologia3010006</ELocationID><Abstract><AbstractText>In October 2020, we conducted a population-based prospective cohort study to determine post-COVID-19 complications, recovery, return to usual health, and associated risk factors in 536 cases of COVID-19 outbreak in Borriana (Spain) by administering an epidemiological questionnaire via phone interviews. A total of 484 patients participated (90.3%), age mean 37.2 &#xb1; 17.1 years, and 301 females (62.2%). Mild illness was the most common COVID-19 manifestation. After six months, 160 patients (33.1%) suffered at least one complication post-COVID-19, and 47 (29.4%) of them sought medical assistance. The most frequent persistent symptoms were hair loss, fatigue, loss of smell or taste, and headache. Risk factors associated with a complication were female sex (adjusted relative risk, [aRR] = 1.93 95% confidence interval [CI] 1.41-2.65), age 35 years and above (aRR = 1.50 95% CI 1.14-1.99), B blood group (aRR = 1.51 95% CI 1.04-2.16), current smoker (RR = 1.61 95% CI 1.02-2.54), and at least a COVID-19 exposure (aRR = 2.13 95% CI 1.11-4.09). Male sex, age younger than 35 years, and low COVID-19 exposures were associated with better recovery and return to usual health. A third of patients presented persistent symptoms compatible with the long-COVID-19 syndrome. In conclusion, an active medical follow-up of post-COVID-19 patients must be implemented.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dom&#xe8;nech-Montoliu</LastName><ForeName>Salvador</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puig-Barber&#xe0;</LastName><ForeName>Joan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5783-0409</Identifier><AffiliationInfo><Affiliation>Vaccines Research Area FISABIO, 46020 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pac-Sa</LastName><ForeName>Maria Rosario</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Public Health Center, 12003 Castell&#xf3; de la Plana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal-Utrillas</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Centers I and II, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latorre-Poveda</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Rio-Gonz&#xe1;lez</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Centers I and II, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrando-Rubert</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Centers I and II, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer-Abad</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Centers I and II, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Urbano</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9629-1601</Identifier><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aparisi-Esteve</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4523-652X</Identifier><AffiliationInfo><Affiliation>Carinyena Health Center, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badenes-Marques</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervera-Ferrer</LastName><ForeName>Belen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clerig-Arnau</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dols-Bernad</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Center, 12200 Onda, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontal-Carcel</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Center, 12600 La Vall d'Uix&#xf3;, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Lanas</LastName><ForeName>Lorna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovani-Sales</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2378-3445</Identifier><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Domingo</LastName><ForeName>Maria Carmen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Villa F&#xe1;tima School, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llopico-Vilanova</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moros-Blasco</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Centers I and II, 12530 Borriana, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Notari-Rodr&#xed;guez</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ru&#xed;z-Puig</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valls-L&#xf3;pez</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Service Hospital de la Plana, 12540 Villarreal, Castellon, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnedo-Pena</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1071-0984</Identifier><AffiliationInfo><Affiliation>Public Health Center, 12003 Castell&#xf3; de la Plana, Castellon, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Science, Public University Navarra, 31006 Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Epidemiologia (Basel)</MedlineTA><NlmUniqueID>9918333886406676</NlmUniqueID><ISSNLinking>2673-3986</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cohort</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">exposure</Keyword><Keyword MajorTopicYN="N">health</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">population-based</Keyword><Keyword MajorTopicYN="N">prospective</Keyword><Keyword MajorTopicYN="N">recovery</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36417267</ArticleId><ArticleId IdType="pmc">PMC9620887</ArticleId><ArticleId IdType="doi">10.3390/epidemiologia3010006</ArticleId><ArticleId IdType="pii">epidemiologia3010006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sridhar S., Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology. 2021;26:652&#x2013;665. doi: 10.1111/resp.14091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14091</ArticleId><ArticleId IdType="pmc">PMC8242464</ArticleId><ArticleId IdType="pubmed">34041821</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme W., Dahake R., Delamou A., Ingelbeen B., Wouters E., Vanham G., van de Pas R., Dossou J.P., Ir P., Abimbola S., et al. The COVID-19 pandemic: Diverse contexts; different epidemics-how and why? BMJ Glob. Health. 2020;5:e003098. doi: 10.1136/bmjgh-2020-003098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003098</ArticleId><ArticleId IdType="pmc">PMC7392634</ArticleId><ArticleId IdType="pubmed">32718950</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The persistent symptoms at the post-viral stage of the disease: A systematic review of the current data. Front. Med. Lausanne. 2021;8:653516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairoli E. &#xbf;De qu&#xe9; hablamos cuando hablamos de pos-COVID-19? Rev. Clin. Esp. 2021;221:614&#x2013;616. doi: 10.1016/j.rce.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8292108</ArticleId><ArticleId IdType="pubmed">34305158</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J. Post-COVID-19 syndrome: Epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev. Neurol. 2021;72:384&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. 2020.  [(accessed on 12 September 2021)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S., Tavahomi M., Zanjari N., Ebrahimi-Takamjani I., Amiri-Arimi S. Physical and mental health complications post-COVID-19: Scoping review. J. Psychosom. Res. 2021;147:110525. doi: 10.1016/j.jpsychores.2021.110525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110525</ArticleId><ArticleId IdType="pmc">PMC8133797</ArticleId><ArticleId IdType="pubmed">34051516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., Kurz K., Koppelst&#xe4;tter S., Haschka D., Petzer V., et al. Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial. Eur. Respir. J. 2021;57:2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Starace M., Iorizzo M., Sechi A., Alessandrini A.M., Carpanese M., Bruni F., Vara G., Apalla Z., Asz-Sigall D., Barruscotti S., et al. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021;5:11&#x2013;18. doi: 10.1016/j.jdin.2021.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdin.2021.07.006</ArticleId><ArticleId IdType="pmc">PMC8328568</ArticleId><ArticleId IdType="pubmed">34368790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei M., Bose D., Nouri-Vaskeh M., Tajiknia V., Zand R., Ghasemi M. Long-term side effects and lingering symptoms post COVID-19 recovery. Rev. Med. Virol. 2021:e2289. doi: 10.1002/rmv.2289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2289</ArticleId><ArticleId IdType="pmc">PMC8646420</ArticleId><ArticleId IdType="pubmed">34499784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzi G., Amaddeo A., Barbi E. Post-COVID syndrome: Turning convalescence into illness? Lancet Reg. Health Eur. 2021;7:100163. doi: 10.1016/j.lanepe.2021.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100163</ArticleId><ArticleId IdType="pmc">PMC8259623</ArticleId><ArticleId IdType="pubmed">34250520</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Postacute COVID-19: An overview and approach to classification. Open Forum Infect. Dis. 2020;7:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A. COVID-19: Not just an acute illness. Trends Urol. Men&#x2019;s Health. 2020;11:17&#x2013;19. doi: 10.1002/tre.776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tre.776</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long covid in adults discharged from UK hospitals after COVID-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B., Erinoso O., Wright K.O., Odusola A.O., Thomas B., Adeyemi O., Bowale A., Adejumo O., Falana A., Abdus-Salam I., et al. &#x2018;Long COVID&#x2019;: Persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect. Dis. 2021;21:304. doi: 10.1186/s12879-020-05716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A., et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno A., Mattavelli D., Rampinelli V., Grammatica A., Raffetti E., Tomasoni M., Gualtieri T., Taboni S., Zorzi S., Del Bon F., et al. Olfactory and gustatory outcomes in COVID-19: A prospective evaluation in nonhospitalized subjects. Otolaryngol. Head Neck Surg. 2020;163:1144&#x2013;1149. doi: 10.1177/0194599820939538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820939538</ArticleId><ArticleId IdType="pmc">PMC7331108</ArticleId><ArticleId IdType="pubmed">32600175</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton D.B., Barrett E.S., Roy J., Gennaro M.L., Andrews T., Greenberg P., Bruiners N., Datta P., Ukey R., Velusamy S.K., et al. Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study. J. Infect. Dis. 2021;224:1345&#x2013;1356. doi: 10.1093/infdis/jiab411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab411</ArticleId><ArticleId IdType="pmc">PMC8436370</ArticleId><ArticleId IdType="pubmed">34387310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S., Zahra H., Royer P.Y., Tipirdamaz C., Mercier J., Gendrin V., Lepiller Q., Marty-Quinternet S., Osman M., Belfeki N., et al. Post-COVID-19 Syndrome: Nine months after SARS-CoV-2 infection in a cohort of 354 patients: Data from the first wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Microorganisms. 2021;9:1719. doi: 10.3390/microorganisms9081719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081719</ArticleId><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xe8;nech-Montoliu S., Pac-Sa M.R., Vidal-Utrillas P., Latorre-Poveda M., Del Rio-Gonz&#xe1;lez A., Ferrando-Rubert S., Ferrer-Abad G., S&#xe1;nchez-Urbano M., Aparisi-Esteve L., Badenes-Marques G., et al. Mass gathering events and COVID-19 transmission in Borriana (Spain): A retrospective cohort study. PLoS ONE. 2021;16:e0256747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389516</ArticleId><ArticleId IdType="pubmed">34437628</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xe8;nech-Montoliu S., Puig-Barber&#xe0; J., Pac-Sa M.R., Vidal-Utrillas P., Latorre-Poveda M., Del Rio-Gonz&#xe1;lez A., Ferrando-Rubert S., Ferrer-Abad G., S&#xe1;nchez-Urbano M., Aparisi-Esteve L., et al. Persistence of anti-SARS-CoV-2 antibodies six months after infection in an outbreak with five hundred COVID-19 cases in Borriana (Spain): A prospective cohort study. COVID. 2021;1:71&#x2013;82. doi: 10.3390/covid1010006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid1010006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xe8;nech-Montoliu S., Puig-Barber&#xe0; J., Pac-Sa M.R., Vidal-Utrillas P., Latorre-Poveda M., Del Rio-Gonz&#xe1;lez A., Ferrando-Rubert S., Ferrer-Abad G., S&#xe1;nchez-Urbano M., Aparisi-Esteve L., et al. ABO blood groups and the incidence of complications in COVID-19 patients: A population-based prospective cohort study. Int. J. Environ. Res. Public Health. 2021;18:10039. doi: 10.3390/ijerph181910039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph181910039</ArticleId><ArticleId IdType="pmc">PMC8507737</ArticleId><ArticleId IdType="pubmed">34639344</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S., Pearl J., Robins J.M. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37&#x2013;48. doi: 10.1097/00001648-199901000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-199901000-00008</ArticleId><ArticleId IdType="pubmed">9888278</ArticleId></ArticleIdList></Reference><Reference><Citation>Textor J., van der Zander B., Gilthorpe M.S., Liskiewicz M., Ellison G.T. Robust causal inference using directed acyclic graphs: The R package &#x2018;dagitty&#x2019;. Int. J. Epidemiol. 2016;45:1887&#x2013;1894. doi: 10.1093/ije/dyw341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw341</ArticleId><ArticleId IdType="pubmed">28089956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant P.W.G., Murray E.J., Arnold K.F., Berrie L., Fox M.P., Gadd S.C., Harrison W.J., Keeble C., Ranker L.R., Textor J., et al. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: Review and recommendations. Int. J. Epidemiol. 2021;50:620&#x2013;632. doi: 10.1093/ije/dyaa213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa213</ArticleId><ArticleId IdType="pmc">PMC8128477</ArticleId><ArticleId IdType="pubmed">33330936</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins J.M., Hern&#xe1;n M.A., Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550&#x2013;560. doi: 10.1097/00001648-200009000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200009000-00011</ArticleId><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley 14/1986, de 25 de Abril, General de Sanidad (Law General of Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/1986/04/25/14/con. (In Spanish)</Citation></Reference><Reference><Citation>Ley 16/2003, de 28 de Mayo, de Cohesi&#xf3;n y Calidad del Sistema Nacional de Salud. (Law of Cohesion and Quality of the National System of Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/2003/05/28/16. (In Spanish)</Citation></Reference><Reference><Citation>Ley 33/2011, de 4 de Octubre, General de Salud P&#xfa;blica (Law General of Public Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/2011/10/04/33/con. (In Spanish)</Citation></Reference><Reference><Citation>Ministry of Health Agreed in the Interterritorial Council of the National Health System  Early Response Plan in a COVID-19 Pandemic Control Scenario. 2020.  [(accessed on 2 August 2021)].  Available online:  https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Plan_de_respuesta_temprana_escenario_control.pdf. (In Spanish)</Citation></Reference><Reference><Citation>Boyraz G., Legros D.N. Coronavirus disease (COVID-19) and traumatic stress: Probable risk factors and correlates of posttraumatic stress disorder. J. Loss Trauma. 2020;25:503&#x2013;522. doi: 10.1080/15325024.2020.1763556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15325024.2020.1763556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Sun Z., Wu L., Zhu Z., Zhang F., Shang Z., Jia Y., Gu J., Zhou Y., Wang Y., et al. Prevalence and risk factors for acute posttraumatic stress disorder during the COVID-19 outbreak. J. Affect. Disord. 2021;15:123&#x2013;129. doi: 10.1016/j.jad.2021.01.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.01.050</ArticleId><ArticleId IdType="pmc">PMC7840403</ArticleId><ArticleId IdType="pubmed">33548905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Nan J., Lv Z., Yang J. Psychological impacts of the COVID-19 epidemic on Chinese people: Exposure, post-traumatic stress symptom, and emotion regulation. Asian Pac. J. Trop. Med. 2020;13:252&#x2013;259.</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R., Rahman M.M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam M.S., Islam M.M. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. 2021;16:e0249644. doi: 10.1371/journal.pone.0249644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., Puhan M.A. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A., Kalleberg K.T., Dahl J.A., S&#xf8;raas C.L., Myklebust T.&#xc5;., Axelsen E., Lind A., B&#xe6;vre-Jensen R., J&#xf8;rgensen S.B., Istre M.S., et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS ONE. 2021;16:e0256142. doi: 10.1371/journal.pone.0256142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256142</ArticleId><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad N.J., Moek F., Steitz F., Murajda L., B&#xe4;rnighausen T., Zoller T., P&#xf6;rtner K., Muller N. A longitudinal study on symptom duration and 60-day clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020. Eurosurveillance. 2021;26:2001757. doi: 10.2807/1560-7917.ES.2021.26.43.2001757.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.43.2001757</ArticleId><ArticleId IdType="pmc">PMC8555372</ArticleId><ArticleId IdType="pubmed">34713798</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic. Clin. Infect. Dis. 2021;73:e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., Rodr&#xed;guez-Jim&#xe9;nez M., Montoya N., Zapata E., Post-COVID Study Group et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 2021;20:102947. doi: 10.1016/j.autrev.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: A population-based study. Int. J. Environ. Res. Public Health. 2021;18:2030. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042030</ArticleId><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Franceschi C., Ferrucci L. A public health perspective of aging: Do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun. Ageing. 2020;17:23. doi: 10.1186/s12979-020-00196-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00196-8</ArticleId><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M., et al. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: A single-center study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L., Valencia I.J., Garvert D.W., Montoya J.G. Onset patterns and course of myalgic encephalomyelitis/Chronic Fatigue Syndrome. Front. Pediatr. 2019;7:12. doi: 10.3389/fped.2019.00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalba Marcos S., Antelo M.L., Galbete A., Etayo M., Ongay E., Garc&#xed;a-Erce J.A. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group. Med. Clin. Barc. 2020;155:340&#x2013;343. doi: 10.1016/j.medcli.2020.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.06.020</ArticleId><ArticleId IdType="pmc">PMC7346773</ArticleId><ArticleId IdType="pubmed">32814635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray J.G., Schull M.J., Vermeulen M.J., Park A.L. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: A population-based cohort study. Ann. Intern. Med. 2021;174:308&#x2013;315. doi: 10.7326/M20-4511.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4511</ArticleId><ArticleId IdType="pmc">PMC7711653</ArticleId><ArticleId IdType="pubmed">33226859</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi S., Suvankar S., Dash D., Panda V.K., Pati A., Panigrahi J., Panda A.K. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. Transfus. Clin. Biol. 2020;27:253&#x2013;258. doi: 10.1016/j.tracli.2020.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tracli.2020.08.009</ArticleId><ArticleId IdType="pmc">PMC7518849</ArticleId><ArticleId IdType="pubmed">32987167</ArticleId></ArticleIdList></Reference><Reference><Citation>Arend P. Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates. Immunobiology. 2021;226:152027. doi: 10.1016/j.imbio.2020.152027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2020.152027</ArticleId><ArticleId IdType="pmc">PMC7609233</ArticleId><ArticleId IdType="pubmed">33706067</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot H.E., Villegas Sierra L.E., Said M.A., Lipsic E., Karper J.C., van der Harst P. Genetically determined ABO blood group and its associations with health and disease. Arter. Thromb. Vasc. Biol. 2020;40:830&#x2013;838. doi: 10.1161/ATVBAHA.119.313658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.313658</ArticleId><ArticleId IdType="pubmed">31969017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes C., Rubenstein W., Gibb D., Klapper E., Tanaka J., Pepkowitz S. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations. Transfusion. 2021;61:2245&#x2013;2249. doi: 10.1111/trf.16524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16524</ArticleId><ArticleId IdType="pmc">PMC8242504</ArticleId><ArticleId IdType="pubmed">34036595</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pendu J., Breiman A., Rocher J., Dion M., Ruvo&#xeb;n-Clouet N. ABO blood types and COVID-19: Spurious, Anecdotal, or truly important relationships? A reasoned review of available data. Viruses. 2021;13:160. doi: 10.3390/v13020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020160</ArticleId><ArticleId IdType="pmc">PMC7911989</ArticleId><ArticleId IdType="pubmed">33499228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloch E.M., Patel E.U., Marshall C., Littlefield K., Goel R., Grossman B.J., Winters J.L., Shrestha R., Burgess I., Laeyendecker O., et al. ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population. Vox Sang. 2021;116:766&#x2013;773. doi: 10.1111/vox.13070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13070</ArticleId><ArticleId IdType="pmc">PMC8012988</ArticleId><ArticleId IdType="pubmed">33493365</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro A.C., Suri R., Emeruwa I.O., Stretch R.J., Cortes-Lopez R.Y., Sherman A., Lindsay C.C., Fulcher J.A., Goodman-Meza D., Sapru A., et al. Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study. PLoS ONE. 2020;15:e0238552. doi: 10.1371/journal.pone.0238552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238552</ArticleId><ArticleId IdType="pmc">PMC7755188</ArticleId><ArticleId IdType="pubmed">33351817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe K.E., Zein J., Hatipoglu U., Attaway A. Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry. JAMA Intern. Med. 2021;181:709&#x2013;711. doi: 10.1001/jamainternmed.2020.8360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.8360</ArticleId><ArticleId IdType="pmc">PMC7835916</ArticleId><ArticleId IdType="pubmed">33492361</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanover C., Mizrahi B., Kalkstein N., Marcus K., Akiva P., Barer Y., Shalev V., Chodick G. What factors increase the risk of complications in SARS-CoV-2-infected patients? A cohort study in a nationwide Israeli health organization. JMIR Public Health Surveill. 2020;6:e20872. doi: 10.2196/20872.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20872</ArticleId><ArticleId IdType="pmc">PMC7451109</ArticleId><ArticleId IdType="pubmed">32750009</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A., Dhingra R., Al-Mulki J., Hassoun M., Alexis N. Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients. PLoS ONE. 2021;16:e0255692. doi: 10.1371/journal.pone.0255692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255692</ArticleId><ArticleId IdType="pmc">PMC8341532</ArticleId><ArticleId IdType="pubmed">34351990</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinelli F., Bianchi F., Drago G., Ruggieri S., Sojic A., Jesuthasan N., Molinaro S., Bastiani L., Maggi S., Noale M., et al. Association between smoking and SARS-CoV-2 infection: Cross-sectional study of the EPICOVID19 internet-based survey. JMIR Public Health Surveill. 2021;7:e27091. doi: 10.2196/27091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/27091</ArticleId><ArticleId IdType="pmc">PMC8081027</ArticleId><ArticleId IdType="pubmed">33668011</ArticleId></ArticleIdList></Reference><Reference><Citation>Calisti R. SARS-CoV-2: Exposure to high external doses as determinants of higher viral loads and of increased risk for COVID-19. A systematic review of the literature. Epidemiol. Prev. 2020;44:152&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">33412806</ArticleId></ArticleIdList></Reference><Reference><Citation>Helle K.B., Sadiku A., Zelleke G.M., Ibrahim T.B., Bouba A., Tsoungui Obama H.C., Jr., Appiah V., Ngwa G.A., Teboh-Ewungkem M.I., Schneider K.A. Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity? PLoS ONE. 2021;16:e0253758. doi: 10.1371/journal.pone.0253758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253758</ArticleId><ArticleId IdType="pmc">PMC8284653</ArticleId><ArticleId IdType="pubmed">34270576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Yuan H., Zhang B., Li W., You J., Liu J., Zhong Q., Zhang L., Chen L., Li S., et al. Comparison of clinical features and CT temporal changes between familial clusters and non-familial patients with COVID-19 pneumonia. Front. Med. Lausanne. 2021;8:630802. doi: 10.3389/fmed.2021.630802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.630802</ArticleId><ArticleId IdType="pmc">PMC8081848</ArticleId><ArticleId IdType="pubmed">33937281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xfc;bner F., Steigert L., Echterdiek F., Jung N., Schmidt-Hellerau K., Zoller W.G., Frick J.S., Feng Y.S., Paul G. Predictors of COVID-19 in an outpatient fever clinic. PLoS ONE. 2021;16:e0254990. doi: 10.1371/journal.pone.0254990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254990</ArticleId><ArticleId IdType="pmc">PMC8294531</ArticleId><ArticleId IdType="pubmed">34288955</ArticleId></ArticleIdList></Reference><Reference><Citation>Fain B., Dobrovolny H.M. Initial inoculum and the severity of COVID-19: A mathematical modeling study of the dose-response of SARS-CoV-2 Infections. Epidemiologia. 2020;1:5&#x2013;15. doi: 10.3390/epidemiologia1010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epidemiologia1010003</ArticleId><ArticleId IdType="pmc">PMC9620883</ArticleId><ArticleId IdType="pubmed">36417207</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen N.C., Papies J., Bajaj T., Emanuel J., Dethloff F., Chua R.L., Trimpert J., Heinemann N., Niemeyer C., Weege F., et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat. Commun. 2021;12:3818. doi: 10.1038/s41467-021-24007-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24007-w</ArticleId><ArticleId IdType="pmc">PMC8217552</ArticleId><ArticleId IdType="pubmed">34155207</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkmann F., M&#xfc;ller M., Reif A., Kahn N., Kreuter M., Trudzinski F., Eichinger M., Heussel C.P., Herth F.J.F. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur. Respir. J. 2021;57:2003002. doi: 10.1183/13993003.03002-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03002-2020</ArticleId><ArticleId IdType="pmc">PMC7821834</ArticleId><ArticleId IdType="pubmed">33479105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. Lond. 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Einvik G., Dammen T., Ghanima W., Heir T., Stavem K. Prevalence and risk factors for post-traumatic stress in hospitalized and non-hospitalized COVID-19 Patients. Int. J. Environ. Res. Public Health. 2021;18:2079. doi: 10.3390/ijerph18042079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042079</ArticleId><ArticleId IdType="pmc">PMC7924607</ArticleId><ArticleId IdType="pubmed">33672759</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidmann M.D., Ofori K., Rai A.J. Laboratory biomarkers in the management of patients with COVID-19. Am. J. Clin. Pathol. 2021;155:333&#x2013;342. doi: 10.1093/ajcp/aqaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa205</ArticleId><ArticleId IdType="pmc">PMC7665296</ArticleId><ArticleId IdType="pubmed">33107558</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado F.V.C., Meys R., Delbressine J.M., Vaes A.W., Go&#xeb;rtz Y.M.J., van Herck M., Houben-Wilke S., Boon G.J.A.M., Barco S., Burtin C., et al. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual. Life Outcomes. 2021;19:40. doi: 10.1186/s12955-021-01691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>